Implications of genotypic differences in the generation of a urinary metabolomics radiation signature

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 788, Issue , 2016, Pages 41-49

  Laiakis, Evagelia C ^a   Pannkuk, Evan L ^a   Diaz Rubio, Maria Elena ^b   Wang, Yi Wen ^a   Mak, Tytus D ^c   Simbulan Rosenthal, Cynthia M ^a   Brenner, David J ^d   Fornace, Albert J ^a,e,f  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Biomarkers; DNA repair; Ionizing radiation; Metabolomics; Urine

Indexed keywords

BIOLOGICAL MARKER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TRICARBOXYLIC ACID; PARP1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; GAMMA RADIATION; GENETIC VARIABILITY; GENOTOXICITY; GENOTYPE; IONIZING RADIATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RADIATION EXPOSURE; RADIOSENSITIVITY; URINALYSIS; URINARY EXCRETION; ANIMAL; GENETICS; KNOCKOUT MOUSE; MALE; RADIATION DOSE; RADIATION RESPONSE; URINE;

ANIMALS; BIOMARKERS; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENOTYPE; MALE; METABOLOME; METABOLOMICS; MICE, KNOCKOUT; POLY (ADP-RIBOSE) POLYMERASE-1; RADIATION DOSAGE; RADIATION, IONIZING;

EID: 84962077654     PISSN: 00275107     EISSN: 18792871     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2016.03.003     Document Type: Article

References (48)

1. Coy S.L., Cheema A.K., Tyburski J.B., Laiakis E.C., Collins S.P., Fornace A.J. Radiation metabolomics and its potential in biodosimetry. Int. J. Radiat. Biol. 2011, 87:802-823.
2. Goudarzi M., Weber W., Mak T.D., Chung J., Doyle-Eisele M., Melo D., et al. Development of urinary biomarkers for internal exposure by cesium-137 using a metabolomics approach in mice. Radiat. Res. 2014, 181:54-64.
3. Goudarzi M., Mak T.D., Chen C., Smilenov L.B., Brenner D.J., Fornace A.J. The effect of low dose rate on metabolomic response to radiation in mice. Radiat. Environ. Biophys. 2014, 53:645-657.
4. Goudarzi M., Weber W.M., Mak T.D., Chung J., Doyle-Eisele M., Melo D.R., et al. A comprehensive metabolomic investigation in urine of mice exposed to strontium-90. Radiat. Res. 2015, 183:665-674.
5. Laiakis E.C., Hyduke D.R., Fornace A.J. Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors γ radiation and lipopolysaccharide. Radiat. Res. 2012, 177:187-199.
6. Laiakis E.C., Mak T.D., Anizan S., Amundson S.A., Barker C.A., Wolden S.L., et al. Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation. Radiat. Res. 2014, 181:350-361.
7. Laiakis E.C., Trani D., Moon B.H., Strawn S.J., Fornace A.J. Metabolomic profiling of urine samples from mice exposed to protons reveals radiation quality and dose specific differences. Radiat. Res. 2015, 183:382-390.
8. Mak T.D., Tyburski J.B., Krausz K.W., Kalinich J.F., Gonzalez F.J., Fornace A.J. Exposure to ionizing radiation reveals global dose- and time-dependent changes in the urinary metabolome of rat. Metabolomics 2015, 11:1082-1094.
9. Pannkuk E.L., Laiakis E.C., Authier S., Wong K., Fornace A.J. Global metabolomic identification of long-term dose-dependent urinary biomarkers in nonhuman primates exposed to ionizing radiation. Radiat. Res. 2015, 184:121-133.
10. Miles E.F., Tatsukawa Y., Funamoto S., Kamada N., Nakashima E., Kodama Y., et al. Biomarkers of radiosensitivity in a-bomb survivors pregnant at the time of bombings in hiroshima and nagasaki. ISRN Obstet. Gynecol. 2011, 2011:264978.
11. Wakeford R., Little M.P., Kendall G.M. Risk of childhood leukemia after low-level exposure to ionizing radiation. Expert Rev. Hematol. 2010, 3:251-254.
12. Gilbert E.S. Ionising radiation and cancer risks: what have we learned from epidemiology. Int. J. Radiat. Biol. 2009, 85:467-482.
13. Protection R. ICRP publication 103. Ann. ICRP 2007; 37: 2, pg. 168, 193.
14. Boice J.D. Radiation epidemiology and recent paediatric computed tomography studies. Ann. ICRP 2015, 44:236-248.
15. Brenner D.J. What we know and what we don't know about cancer risks associated with radiation doses from radiological imaging. Br. J. Radiol. 2014, 87:20130629.
16. Glover D., Harmer V. Radiotherapy-induced skin reactions: assessment and management. Br. J. Nurs. 2014, 23(S28):S30-S35.
17. Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2. 2006; xvi, 406, Ch. 3.
18. Twardella D., Chang-Claude J. Studies on radiosensitivity from an epidemiological point of view- overview of methods and results. Radiother. Oncol. 2002, 62:249-260.
19. Patrono C., Sterpone S., Testa A., Cozzi R. Polymorphisms in base excision repair genes: breast cancer risk and individual radiosensitivity. World J. Clin. Oncol. 2014, 5:874-882.
20. Kim M.Y., Zhang T., Kraus W.L. Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev. 2005, 19:1951-1967.
21. Bai P., Cantó C., Oudart H., Brunyánszki A., Cen Y., Thomas C., et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011, 13:461-468.
22. Bai P., Cantó C. The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease. Cell Metab. 2012, 16:290-295.
23. Módis K., Gero D., Erdélyi K., Szoleczky P., Dewitt D., Szabo C. Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress. Biochem. Pharmacol. 2012, 83:633-643.
24. Rossi M.N., Carbone M., Mostocotto C., Mancone C., Tripodi M., Maione R., et al. Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. J. Biol. Chem. 2009, 284:31616-31624.
25. Szczesny B., Brunyanszki A., Olah G., Mitra S., Szabo C. Opposing roles of mitochondrial and nuclear PARP1 in the regulation of mitochondrial and nuclear DNA integrity: implications for the regulation of mitochondrial function. Nucleic Acids Res. 2014, 42:13161-13173.
26. Alanazi M., Pathan A.A., Abduljaleel Z., Arifeen Z., Shaik J.P., Alabdulkarim H.A., et al. Association between PARP-1 V762A polymorphism and breast cancer susceptibility in Saudi population. PLoS One 2013, 8:e85541.
27. Alshammari A.H., Shalaby M.A., Alanazi M.S., Saeed H.M. Novel mutations of the PARP-1 gene associated with colorectal cancer in the Saudi population. Asian Pac. J. Cancer Prev. 2014, 15:3667-3673.
28. Masutani M., Nozaki T., Nakamoto K., Nakagama H., Suzuki H., Kusuoka O., et al. The response of Parp knockout mice against DNA damaging agents. Mutat. Res. 2000, 462:159-166.
29. Mak T.D., Laiakis E.C., Goudarzi M., Fornace A.J. MetaboLyzer: a novel statistical workflow for analyzing postprocessed LC-MS metabolomics data. Anal. Chem. 2014, 86:506-513.
30. Caspi R., Altman T., Billington R., Dreher K., Foerster H., Fulcher C.A., et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 2014, 42:D459-D471.
31. Kanehisa M., Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28:27-30.
32. Kanehisa M., Goto S., Sato Y., Kawashima M., Furumichi M., Tanabe M. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014, 42:D199-D205.
33. Wishart D.S., Jewison T., Guo A.C., Wilson M., Knox C., Liu Y., et al. HMDB 3.0- the Human Metabolome Database in 2013. Nucleic Acids Res. 2013, 41:D801-D807.
34. Smith C.A., O'maille G., Want E.J., Qin C., Trauger S.A., Brandon T.R., et al. METLIN: a metabolite mass spectral database. Ther. Drug Monit. 2005, 27:747-751.
35. De Murcia J.M., Niedergang C., Trucco C., Ricoul M., Dutrillaux B., Mark M., et al. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:7303-7307.
36. Tyburski J.B., Patterson A.D., Krausz K.W., Slavík J., Fornace A.J., Gonzalez F.J., et al. Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat. Res. 2008, 170:1-14.
37. Pollard J.M., Gatti R.A. Clinical radiation sensitivity with DNA repair disorders: an overview. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74:1323-1331.
38. Harper J.L., Franklin L.E., Jenrette J.M., Aguero E.G. Skin toxicity during breast irradiation: pathophysiology and management. South. Med. J. 2004, 97:989-993.
39. Valentin J. Radiopathology of skin and eye and radiation risk. Ann. ICRP 2000, 30:25-31.
40. Johnson C.H., Patterson A.D., Krausz K.W., Kalinich J.F., Tyburski J.B., Kang D.W., et al. Radiation metabolomics. 5. Identification of urinary biomarkers of ionizing radiation exposure in nonhuman primates by mass spectrometry-based metabolomics. Radiat. Res. 2012, 178:328-340.
41. Mak T.D., Tyburski J.B., Krausz K.W., Kalinich J.F., Gonzalez F.J., Fornace A.J. Exposure to ionizing radiation reveals global dose-and time-dependent changes in the urinary metabolome of rat. Metabolomics 2014, 1-13.
42. Kurland I.J., Broin P.Ó., Golden A., Su G., Meng F., Liu L., et al. Integrative metabolic signatures for hepatic radiation injury. PLoS One 2015, 10:e0124795.
43. Tran L.K., Maturen K.E., Feng M.U., Wizauer E., Watcharotone K., Ellis J.H. Renal remodeling in the first 24 months after abdominal radiotherapy. Pract. Radiat. Oncol. 2013, 3:S6.
44. Tran L.K., Maturen K.E., Feng M.U., Wizauer E.J., Watcharotone K., Parker R.A., et al. Renal remodeling after abdominal radiation therapy: parenchymal and functional changes. AJR Am. J. Roentgenol. 2014, 203:W192-W198.
45. Gerber G.B., Gertler P., Altman K.I., Hempelmann L.H. Dose dependency of radiation-induced creatine excretion in rat urine. Radiat. Res. 1961, 15:307-313.
46. Noren Hooten N., Kompaniez K., Barnes J., Lohani A., Evans M.K. Poly(ADP-ribose) polymerase 1 (PARP-1) binds to 8-oxoguanine-DNA glycosylase (OGG1). J. Biol. Chem. 2011, 286:44679-44690.
47. Surjana D., Halliday G.M., Damian D.L. Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. J. Nucleic. Acids 2010, 2010.
48. Li H.H., Wang Y.W., Chen R., Zhou B., Ashwell J.D., Fornace A.J. Ionizing radiation impairs T cell activation by affecting metabolic reprogramming. Int. J. Biol. Sci. 2015, 11:726-736.